pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,338 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1772Endpoints1382Fierce Biotech700BioSpace694BioPharma Dive522raps231onclive165fda recalls111
therapy area
allOncology12282Rare Disease3188Immunology2860Cardiology2725Hematology2166Pulmonology2136Vaccines
  • VC Julie Grant argues U.S. should not restrict biotech investments in China
    Julie Grant, a venture capitalist, told STAT+ that she opposes any U.S. effort to limit biotech investments in China. She says the biotech sector has become increasingly interdependent over decade…
    STAT · 4mo agoRegulatoryNeutral↗ source
  • FDA approves first generic single-dose baloxavir tablet for flu treatment and prevention
    FDA announced approval of the first generic version of Xofluza (baloxavir marboxil) tablets, a single-dose treatment for acute uncomplicated influenza and prophylaxis for patients five years of age…
    fda press · 4mo agoApprovalPositive↗ source
← prev
page 68 of 94
next →
fda medwatch109
globenewswire health73
fda press59
1794
Psychiatry & CNS1200
Ophthalmology1049
Endocrinology & Metabolism775
Pain773
Nephrology759
  • FTC and Four State Attorneys General Sue Transgender Health Group Over Alleged Misleading Claims
    The Federal Trade Commission, together with attorneys general from Alaska, Iowa, Nebraska and Texas, filed a lawsuit on Wednesday in a Texas federal court against the World Professional Association…
    STAT · 4mo agoRegulatoryNegative↗ source
  • NIH Diversity Programs Found to Double Undergraduate PhD Odds in 20-Year Study
    A 20‑year study published in Science Advances reports that two NIH‑funded diversity initiatives, the Research Initiative for Scientific Enhancement (RISE) and Minority Access to Research Careers (M…
    STAT · 4mo agoNeutral↗ source
  • Trump administration moves special-education oversight to Health and Human Services
    The Trump administration announced that responsibility for special education will be transferred from the Department of Education to the Department of Health and Human Services. This change is part…
    STAT · 4mo agoRegulatoryNeutral↗ source
  • Advocacy groups urge FDA to revoke approval of antibiotics used for disease prevention in livestock
    More than 60 organizations have filed a petition with the FDA asking the agency to withdraw its approval for the use of antibiotics in food‑producing animals for disease prevention and growth promo…
    STAT · 4mo agoRegulatoryNegative↗ source
  • Abridge’s Patient-Centered Claim Scrutinized in STAT AI Prognosis
    Brittany Trang, a health‑tech reporter, wrote a piece for STAT’s AI Prognosis newsletter that takes a close look at Abridge’s assertion that its ambient scribe platform is "patient‑centered." The…
    STAT · 4mo agoNegative↗ source
  • Oncologists Find Deep Joy in Delivering Hope to Patients and Families
    Khushali Jhaveri, a lymphoma specialist at Indiana University, shares a personal view of what makes oncology rewarding. She recounts a recent encounter with a patient who had endured multiple trans…
    STAT · 4mo agoPositive↗ source
  • STAT decides to keep “health care” as two words despite AP style change
    STAT’s editorial team faced a dilemma after the Associated Press Stylebook announced that “healthcare” will now be written as a single word. The change, revealed at the AP Editors Conference, spark…
    STAT · 4mo agoNeutral↗ source
  • Murder suspect plans psychiatric defense in killing of UnitedHealthcare CEO
    Luigi Mangione has told the court he will rely on a psychiatric defense, arguing that he was suffering from extreme emotional disturbance when he shot UnitedHealthcare chief Brian Thompson. If a j…
    STAT · 4mo agoNegative↗ source
  • Medicare to Cover Obesity Drugs for Adults 65+ Starting Next Month
    Medicare will begin covering prescription weight‑loss medications for beneficiaries aged 65 and older starting next month, marking the first time the program includes such drugs. The coverage is p…
    STAT · 4mo agoRegulatoryPositive↗ source
  • FDA approves OTC naloxone nasal spray Rextovy, expanding consumer access to overdose treatment
    The FDA announced approval of a new over-the-counter naloxone nasal spray called Rextovy, delivering 4 mg of naloxone hydrochloride for emergency reversal of opioid overdose. The product can be pu…
    fda press · 4mo agoApprovalPositive↗ source
  • Biotech Converts Failed Trial Data into AI Model
    A biotech startup recently faced a setback when a clinical trial did not achieve its primary goals. Rather than discarding the results, the company chose to analyze the data for new insights. The…
    STAT · 4mo agoPositive↗ source
  • Verge Labs launches AI tool to boost patient enrollment and trial efficiency; Moderna appoints new chief commercial officer
    Verge Labs announced a new artificial‑intelligence model designed to identify patients most likely to respond to a therapy, aiming to reduce dropout rates and increase the statistical power of clin…
    STAT · 4mo agoPositive↗ source
  • Verge Labs launches AI tool to improve neurology trial patient selection after ALS setback
    Verge Labs, formerly known as Verge Genomics, announced a new artificial intelligence model designed to address patient stratification challenges in neurology clinical trials. The company says the…
    STAT · 4mo agoPositive↗ source
  • Congress urged to swiftly reauthorize Pandemic and All-Hazards Preparedness Act
    Former assistant secretary for preparedness Craig Vanderwagen and former Senate staffer Jennifer Alton argue that the Pandemic and All-Hazards Preparedness Act needs prompt reauthorization. They no…
    STAT · 4mo agoRegulatoryNeutral↗ source
  • U.S. infant mortality hits record low in 2025, though still behind peer nations
    Preliminary CDC data show the United States recorded its lowest infant mortality rate ever in 2025. The rate fell to just under 5.4 deaths per 1,000 live births. That figure represents a modest de…
    STAT · 4mo agoPositive↗ source
  • US spends $360,000 storing contraceptives meant for African aid, with most supplies nearing expiration
    The U.S. government spent roughly $360,000 between January 2025 and March 2026 to keep millions of dollars worth of contraceptives in climate-controlled storage, according to a recent USAID Office…
    STAT · 4mo agoNeutral↗ source
  • Human Cell Atlas leadership ties to 10x Genomics spark conflict-of-interest concerns
    The International Human Cell Atlas Consortium is marking its 10-year anniversary with a meeting in Boston that brings together academic and industry leaders. Attention has turned to one of the pro…
    STAT · 4mo agoNegative↗ source
  • Alzheimer specialist admits she missed early signs in her own father, urging earlier detection
    A neurologist at the University of California, San Diego writes about her personal experience when her father began showing subtle cognitive changes that were missed. She recounts small mistakes a…
    STAT · 4mo agoNegative↗ source
  • FDA grants accelerated approval for Tzield to delay insulin loss in children with newly diagnosed Stage 3 type 1 diabetes
    The U.S. Food and Drug Administration issued an accelerated approval on June 12, 2026 for Tzield (teplizumab) to slow the decline of insulin production in pediatric patients aged 8 to 17 who have r…
    fda press · 4mo agoApprovalPositive↗ source
  • Medicare to cover GLP-1 weight-loss drugs for seniors under temporary Trump-backed program
    Starting July 1, Medicare will make GLP-1 weight-loss drugs available to adults 65 and older at a cost of $50 per prescription through a new demonstration program. The initiative, called Bridge, i…
    STAT · 4mo agoRegulatoryNeutral↗ source
  • Newborn contracts preventable syphilis amid Pfizer emergency penicillin shortage and procedural delays
    In March 2026 a pregnant woman in Gila County, Arizona tested positive for syphilis. Doctors said she needed an injectable penicillin dose at least 30 days before delivery to avoid severe fetal com…
    STAT · 4mo agoRegulatoryNegative↗ source
  • FDA greenlights Colorado's plan to import prescription drugs from Canada to lower costs
    The FDA announced Monday that Colorado will be allowed to bring in certain prescription medicines from Canada, aiming to reduce drug prices for state residents. This decision makes Colorado the se…
    STAT · 4mo agoApprovalPositive↗ source
  • FDA greenlights Colorado plan to import prescription drugs from Canada to lower prices
    FDA announced Monday that Colorado will be allowed to import certain prescription medicines from Canada, making it the second state to receive such authorization after Florida. The move is intende…
    STAT · 4mo agoApprovalPositive↗ source